Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal of Clinical Endocrinolgy and Metabolism (JCEM), Climacteric and the Journal of Sexual Medicine in 14 languages.
Read the full paper at https://www.imsociety.org/position_papers_and_consensus_statements.php
Latest News
AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
The Menopause Charity launches in the UK
Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →